Please use this identifier to cite or link to this item:
Title: Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature
Author: Aerts, Céline
Sunyoto, Temmy
Tediosi, Fabrizio
Sicuri, Elisa
Keywords: Medicina tropical
Indústria farmacèutica
Salut Pública
Avaluació del risc per la salut
Tropical medicine
Pharmaceutical industry
Public Health
Health risk assessment
Issue Date: 19-May-2017
Publisher: Elsevier B. V.
Abstract: Pharmaceutical companies are reluctant to invest in research and development (R&D) of products for neglected tropical diseases (NTDs) mainly due to the low ability-to-pay of health insurance systems and of potential consumers. The available preventive and curative interventions for NTDs mostly rely on old technologies and products that are often not adequate. Moreover, NTDs mostly affect populations living in remote rural areas and conflict zones, thereby hampering access to healthcare. The challenges posed by NTDs have led to the proliferation of a variety of public-private partnerships (PPPs) in the last decades. We conducted a systematic review to assess the functioning and impact of these partnerships on the development of and access to better technologies for NTDs. Our systematic review revealed a clear lack of empirical assessment of PPPs: we could not find any impact evaluation analyses, while these are crucial to realize the full potential of PPPs and to progress further towards NTDs elimination.
Note: Reproducció del document publicat a:
It is part of: Health Policy, 2017, vol. 121, num. 7, p. 745-754
Related resource:
ISSN: 0168-8510
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
aerts20172568.pdf543.93 kBAdobe PDFView/Open    Request a copy

Embargat   Document embargat fins el 19-5-2018

This item is licensed under a Creative Commons License Creative Commons